Don’t forget to check out our premarket coverage here .
Read This Next: Why Fear Level Among US Investors Is Increasing
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
August 01, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, August 1, 2022DBV Technologies Reports Second Quarter 2022…
November 03, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, November 3, 2022DBV Technologies Reports Third Quarter Financial…
June 07, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, June 7, 2022DBV Technologies Announces Positive Topline Results…
Montrouge, France, December 23, 2022 DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial DBV expects to initiate patient screening…
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:Shares of DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) have…
